Mimedx (MDXG) Free Cash Flow (2011 - 2026)
Mimedx recorded quarterly Free Cash Flow of $1.3 million in Q1 2026, down 94.69% quarter-over-quarter from $24.7 million in Q4 2025, and down 73.41% year-over-year from $4.9 million in Q1 2025.
Mimedx's Free Cash Flow history runs 16 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 73.41% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $69.4 million (up 5.84% YoY), while the FY2025 annual figure was $73.0 million, up 11.5% from the prior year.
- Free Cash Flow came in at $1.3 million for Q1 2026 at Mimedx, down from $24.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $29.1 million in Q3 2025 to a low of -$10.3 million in Q1 2022.
- A 5-year average of $9.1 million and a median of $7.5 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow sank 383.5% in 2022 and jumped 2149.67% in 2023, its largest moves.
- Mimedx's Free Cash Flow stood at $3.6 million in 2022, then soared by 127.82% to $8.3 million in 2023, then surged by 135.18% to $19.4 million in 2024, then increased by 26.85% to $24.7 million in 2025, then slumped by 94.69% to $1.3 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $1.3 million, $24.7 million, and $29.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 24.67 Mn |
| Dec 31, 2025 | 24.67 Mn |
| Sep 30, 2025 | 29.14 Mn |
| Sep 30, 2025 | 29.14 Mn |
| Jun 30, 2025 | 14.24 Mn |
| Jun 30, 2025 | 14.24 Mn |
| Mar 31, 2025 | 4.92 Mn |
| Mar 31, 2025 | 4.92 Mn |
| Dec 31, 2024 | 19.45 Mn |
| Dec 31, 2024 | 19.45 Mn |
| Sep 30, 2024 | 18.52 Mn |
| Sep 30, 2024 | 18.52 Mn |
| Jun 30, 2024 | 22.64 Mn |
| Jun 30, 2024 | 22.64 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 13.72 Mn |
| Sep 30, 2023 | 13.72 Mn |
| Jun 30, 2023 | 7.48 Mn |
| Jun 30, 2023 | 7.48 Mn |
| Mar 31, 2023 | -4.68 Mn |
| Mar 31, 2023 | -4.68 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 610,000.00 |
| Sep 30, 2022 | 610,000.00 |
| Jun 30, 2022 | -3.39 Mn |
| Jun 30, 2022 | -3.39 Mn |
| Mar 31, 2022 | -10.34 Mn |
| Mar 31, 2022 | -10.34 Mn |
| Dec 31, 2021 | -11.45 Mn |
| Dec 31, 2021 | -11.45 Mn |
| Sep 30, 2021 | 5.78 Mn |
| Sep 30, 2021 | 5.78 Mn |
| Jun 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 1.19 Mn |
| Mar 31, 2021 | -8.62 Mn |
| Mar 31, 2021 | -8.62 Mn |
| Dec 31, 2020 | -12.42 Mn |
| Dec 31, 2020 | -12.42 Mn |
| Sep 30, 2020 | -5.27 Mn |
| Sep 30, 2020 | -5.27 Mn |
| Jun 30, 2020 | -3.51 Mn |
| Jun 30, 2020 | -3.51 Mn |
| Mar 31, 2020 | -13.29 Mn |
| Mar 31, 2020 | -13.29 Mn |
| Dec 31, 2019 | -23.82 Mn |
| Dec 31, 2019 | -23.82 Mn |
| Sep 30, 2019 | -3.32 Mn |
| Sep 30, 2019 | -3.32 Mn |
| Jun 30, 2019 | 1.88 Mn |
| Jun 30, 2019 | 1.88 Mn |
| Mar 31, 2019 | -15.91 Mn |
| Mar 31, 2019 | -15.91 Mn |
| Dec 31, 2018 | -295,000.00 |
| Dec 31, 2018 | -295,000.00 |
| Sep 30, 2018 | 1.35 Mn |
| Sep 30, 2018 | 1.35 Mn |
| Jun 30, 2018 | 18.22 Mn |
| Jun 30, 2018 | 18.22 Mn |
| Mar 31, 2018 | 7.11 Mn |
| Mar 31, 2018 | 7.11 Mn |
| Dec 31, 2017 | 19.74 Mn |
| Dec 31, 2017 | 19.74 Mn |
| Sep 30, 2017 | 13.97 Mn |
| Sep 30, 2017 | 13.97 Mn |
| Jun 30, 2017 | 13.48 Mn |
| Jun 30, 2017 | 13.48 Mn |
| Mar 31, 2017 | 10.63 Mn |
| Mar 31, 2017 | 10.63 Mn |
| Dec 31, 2016 | 19.90 Mn |
| Dec 31, 2016 | 19.90 Mn |
| Sep 30, 2016 | 1.30 Mn |
| Sep 30, 2016 | 1.30 Mn |
| Jun 30, 2016 | 5.53 Mn |
| Jun 30, 2016 | 5.53 Mn |
| Mar 31, 2016 | -2.99 Mn |
| Mar 31, 2016 | -2.99 Mn |
| Dec 31, 2015 | 2.71 Mn |
| Dec 31, 2015 | 2.71 Mn |
| Sep 30, 2015 | 5.65 Mn |
| Sep 30, 2015 | 5.65 Mn |
| Jun 30, 2015 | 1.77 Mn |
| Jun 30, 2015 | 1.77 Mn |
| Mar 31, 2015 | 2.86 Mn |
| Mar 31, 2015 | 2.86 Mn |
| Dec 31, 2014 | 5.82 Mn |
| Dec 31, 2014 | 5.82 Mn |
| Sep 30, 2014 | 8.92 Mn |
| Sep 30, 2014 | 8.92 Mn |
| Jun 30, 2014 | 1.15 Mn |
| Jun 30, 2014 | 1.15 Mn |
| Mar 31, 2014 | -1.65 Mn |
| Mar 31, 2014 | -1.65 Mn |
| Dec 31, 2013 | 2.79 Mn |
| Dec 31, 2013 | 2.79 Mn |
| Sep 30, 2013 | 773,408.00 |
| Sep 30, 2013 | 773,408.00 |
| Jun 30, 2013 | -1.73 Mn |
| Jun 30, 2013 | -1.73 Mn |
| Mar 31, 2013 | -2.17 Mn |
| Mar 31, 2013 | -2.17 Mn |
| Dec 31, 2012 | -1.11 Mn |
| Dec 31, 2012 | -1.11 Mn |
| Sep 30, 2012 | -1.03 Mn |
| Sep 30, 2012 | -1.03 Mn |
| Jun 30, 2012 | -549,370.00 |
| Jun 30, 2012 | -549,370.00 |
| Mar 31, 2012 | -1.29 Mn |
| Mar 31, 2012 | -1.29 Mn |
| Dec 31, 2011 | -2.14 Mn |
| Dec 31, 2011 | -2.14 Mn |
| Sep 30, 2011 | -946,136.00 |
| Sep 30, 2011 | -946,136.00 |
| Jun 30, 2011 | -2.16 Mn |
| Jun 30, 2011 | -2.16 Mn |
| Mar 31, 2011 | -1.90 Mn |
| Mar 31, 2011 | -1.90 Mn |